Prevalence, Characteristics, and Prognostic Significance of HFE Gene Mutations in Type 2 Diabetes: The Fremantle Diabetes Study
| dc.contributor.author | Davis, T. | |
| dc.contributor.author | Beilby, J. | |
| dc.contributor.author | Davis, W. | |
| dc.contributor.author | Olynyk, John | |
| dc.contributor.author | Jeffrey, G. | |
| dc.contributor.author | Rossi, E. | |
| dc.contributor.author | Boyder, C. | |
| dc.contributor.author | Bruce, D. | |
| dc.date.accessioned | 2017-01-30T10:33:07Z | |
| dc.date.available | 2017-01-30T10:33:07Z | |
| dc.date.created | 2014-10-08T03:10:45Z | |
| dc.date.issued | 2008 | |
| dc.identifier.citation | Davis, T. and Beilby, J. and Davis, W. and Olynyk, J. and Jeffrey, G. and Rossi, E. and Boyder, C. et al. 2008. Prevalence, Characteristics, and Prognostic Significance of HFE Gene Mutations in Type 2 Diabetes: The Fremantle Diabetes Study. Diabetes Care. 31 (9): pp. 1795-1801. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/3646 | |
| dc.publisher | American Diabetes Association | |
| dc.title | Prevalence, Characteristics, and Prognostic Significance of HFE Gene Mutations in Type 2 Diabetes: The Fremantle Diabetes Study | |
| dc.type | Journal Article | |
| dcterms.source.volume | 31 | |
| dcterms.source.number | 9 | |
| dcterms.source.startPage | 1795 | |
| dcterms.source.endPage | 1801 | |
| dcterms.source.issn | 0149-5992 | |
| dcterms.source.title | Diabetes Care | |
| curtin.accessStatus | Fulltext not available |